CD44 and hepatocellular carcinoma: In particular, the non-invasive, epithelial “early” TGF-β signature HCCcells express EPCAM, ANPEP, KRT19 and PROM1, whereas the invasive, mesenchymal“late” TGF-β signature HCC cells express CD44 and THY1.